These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8157573)

  • 21. Investigation by syringe method of effect of tampons on production in vitro of toxic shock syndrome toxin 1 by Staphylococcus aureus.
    Lee AC; Crass BA; Bergdoll MS
    J Clin Microbiol; 1987 Jan; 25(1):87-90. PubMed ID: 3793877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amino acid requirements of Staphylococcus aureus strains from Germany and Austria that produce toxic shock syndrome toxin-1 (TSST-1).
    Dickgiesser N; Eppli P
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Mar; 268(1):1-7. PubMed ID: 3394445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxygen and carbon dioxide regulation of toxic shock syndrome toxin 1 production by Staphylococcus aureus MN8.
    Yarwood JM; Schlievert PM
    J Clin Microbiol; 2000 May; 38(5):1797-803. PubMed ID: 10790102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of topical antimicrobial agents on the production of toxic shock syndrome toxin-1.
    Edwards-Jones V; Foster HA
    J Med Microbiol; 1994 Dec; 41(6):408-13. PubMed ID: 7966218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of immune cell proliferation by glycerol monolaurate.
    Witcher KJ; Novick RP; Schlievert PM
    Clin Diagn Lab Immunol; 1996 Jan; 3(1):10-3. PubMed ID: 8770497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of arbekacin on the production of toxic shock syndrome toxin 1 by methicillin-resistant Staphylococcus aureus].
    Miyata A; Araake M; Ogawa H; Hanaki H; Hiramatsu K
    Jpn J Antibiot; 2001 Jul; 54(7):372-81. PubMed ID: 11560056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Production of toxic shock syndrome toxin 1 by Staphylococcus aureus under aerobic and anaerobic conditions and the effect of magnesium ion limitation.
    Taylor D; Holland KT
    Rev Infect Dis; 1989; 11 Suppl 1():S151-6. PubMed ID: 2928631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of magnesium on production of toxic-shock-syndrome toxin-1: a collaborative study.
    Kass EH; Schlievert PM; Parsonnet J; Mills JT
    J Infect Dis; 1988 Jul; 158(1):44-51. PubMed ID: 3134495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycerol monolaurate antibacterial activity in broth and biofilm cultures.
    Schlievert PM; Peterson ML
    PLoS One; 2012; 7(7):e40350. PubMed ID: 22808139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of air in growth and production of toxic shock syndrome toxin 1 by Staphylococcus aureus in experimental cotton and rayon tampons.
    Fischetti VA; Chapman F; Kakani R; James J; Grun E; Zabriskie JB
    Rev Infect Dis; 1989; 11 Suppl 1():S176-81. PubMed ID: 2928634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Staphylococcus aureus isolates from patients with nonmenstrual toxic shock syndrome. Evidence for additional toxins.
    Garbe PL; Arko RJ; Reingold AL; Graves LM; Hayes PS; Hightower AW; Chandler FW; Broome CV
    JAMA; 1985 May; 253(17):2538-42. PubMed ID: 3981783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of focal growth conditions on the pathogenesis of toxic shock syndrome.
    Todd JK; Todd BH; Franco-Buff A; Smith CM; Lawellin DW
    J Infect Dis; 1987 Apr; 155(4):673-81. PubMed ID: 3546518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation and control of toxic shock syndrome toxin 1: overview.
    Bergdoll MS
    Rev Infect Dis; 1989; 11 Suppl 1():S142-4. PubMed ID: 2648538
    [No Abstract]   [Full Text] [Related]  

  • 34. Control of production of toxic-shock-syndrome toxin-1 (TSST-1) by magnesium ion.
    Mills JT; Parsonnet J; Tsai YC; Kendrick M; Hickman RK; Kaśs EH
    J Infect Dis; 1985 Jun; 151(6):1158-61. PubMed ID: 3998512
    [No Abstract]   [Full Text] [Related]  

  • 35. Toxic shock syndrome: the effect of solid phase materials on the physiology of Staphylococcus aureus.
    Holland KT; Ingham E; Eady EA; Gowland G
    Postgrad Med J; 1985; 61 Suppl 1():39-43. PubMed ID: 4059158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxic shock syndrome toxin-1 (TSST-1): influence of its production by subinhibitory antibiotic concentrations.
    Dickgiesser N; Wallach U
    Infection; 1987; 15(5):351-3. PubMed ID: 3692606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Production of toxic shock syndrome toxin 1 by Staphylococcus aureus as determined by tampon disk-membrane-agar method.
    Robbins RN; Reiser RF; Hehl GL; Bergdoll MS
    J Clin Microbiol; 1987 Aug; 25(8):1446-9. PubMed ID: 3624442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycerol monolaurate inhibits virulence factor production in Bacillus anthracis.
    Vetter SM; Schlievert PM
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1302-5. PubMed ID: 15793101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnesium and the production of toxic-shock-syndrome toxin-1 by Staphylococcus aureus.
    Tierno PM; Hanna BA
    J Infect Dis; 1986 May; 153(5):994-6. PubMed ID: 3701112
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of cotton and cotton/rayon tampons for effect on production of toxic shock syndrome toxin.
    Schlievert PM
    J Infect Dis; 1995 Oct; 172(4):1112-4. PubMed ID: 7561191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.